Chatbot takes on chemsex: new trial aims to cut HIV risks
NCT ID NCT07472582
First seen Mar 18, 2026 · Last updated Apr 30, 2026 · Updated 5 times
Summary
This study tests whether a chatbot can help men who have sex with men in Hong Kong reduce chemsex (using drugs before or during sex) and related HIV risks. About 100 men will be split into two groups: one gets weekly videos on chemsex harm reduction, and the other gets those videos plus a chatbot that delivers personalized advice over 12 weeks. Researchers will check if the chatbot group reports less chemsex after 3 and 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BEHAVIOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.